Lung graphic About Pulmonary ReviewsFeatured IssuesEditorial BoardPublishing StaffAdvertising InformationSubscription InformationOnline CME from Jobson Medical Group Classifieds

Search:
Sort by:


Pulmonary Reviews.Com

Home  |  Contact Us  |  Archives


Vol. 5, No. 4
April 2000


DVT AND SILENT PE:
WHEN ARE LUNG SCANS INDICATED?

CRÉTEIL, FRANCE--Silent pulmonary embolism (PE) is widespread in patients with deep venous thrombosis (DVT), and lung scans can help detect asymptomatic disease in many patients, according to the results of a recent international study of more than 600 patients.[1] However, baseline lung scans are less useful in predicting early thromboembolic recurrences during therapy. These findings underscore the importance of proper prophylaxis against and treatment for venous thromboembolism (VTE).

"Regardless of what interpretive criteria are used for assessing lung scans … the frequency of silent PE is 40% to 50% in patients with DVT," concluded the study authors, who were led by Michel Meignan, MD, of Henri Mondor Hospital, Créteil, France. However, they added, "Routine baseline lung scans for diagnosing asymptomatic PE in patients with DVT may not be necessary. The abnormalities may be of no clinical significance, as they seem nonpredictive of PE recurrence, at least after three months of therapy."

STUDY METHODOLOGY

As part of a multicenter prospective trial of low-molecular-weight heparin in DVT patients, Dr. Meignan and colleagues used perfusion lung scans to estimate the frequency of PE in DVT patients. Subjects included 622 outpatients who had a primary diagnosis of proximal DVT confirmed by venography but no clinical indication of PE. All patients underwent perfusion lung scanning, and 379 of these patients also had ventilation scans. As part of the three-month follow-up, patients with suspected PE received a second perfusion or perfusion-ventilation lung scan, and PE was diagnosed if the scan showed a new segmental perfusion defect. When the diagnosis was uncertain, pulmonary angiography was performed.

Table 1

Recommended Therapies for VTE Prophylaxis

Surgical procedure Regimen
Major abdominal surgery

Low-molecular-weight heparin (enoxaparin sodium,

30 mg bid; or dalteparin sodium, 2500 µ/d*) or

Low-dose unfractionated heparin every 8 hours‡ or

Intermittent pneumatic compression‡

Total hip replacement

Low-molecular-weight heparin or

Warfarin or

Adjusted-dose unfractionated heparin

Hip fracture repair

 

Low-molecular-weight heparin or

Warfarin

Total knee replacement

Low-molecular-weight heparin or

Intermittent pneumatic compression

*At least one injection during hospitalization
‡Initiated during hospitalization

Data extracted from Clagett GP, et al; 1995[1] and Stratton MA, et al; 2000.[2]

PROBABILITIES AND FREQUENCIES

Lung scans were categorized as normal, low probability, intermediate probability, or high probability, depending on the abnormalities present. Scans were considered normal when perfusion was normal, and very low probability if the abnormalities were limited to no more than three small perfusion defects.

High-probability scans were defined by the presence of segmental defects associated with either normal ventilation and normal chest films (ventilation-perfusion mismatched) or with normal chest films alone (chest radiograph/perfusion mismatched). Intermediate-probability scans were those that did not fit into any of the other three categories. PE frequency was then approximated by combining the lung scan probabilities with the positive predictive values for PE that had previously been reported for those scan results.

FINDINGS

The researchers found that the frequency of PE was 39.5% when high-probability scans were defined by at least two mismatched ventilation-perfusion defects. When one mismatched defect was the criterion, PE frequency was 49.5%. When perfusion scans were compared to chest films rather than ventilation scans, the PE frequency was calculated at 45.3%.

From these calculations of PE frequency, the researchers concluded that "a high percentage of patients [with DVT] have lung scans that fulfill the criteria for a high probability of PE regardless of the criteria used for scan analysis." They further suggested that the frequency of silent PE was probably closer to the highest value (49.5%), because of the deliberate exclusion of moderate mismatched defects in the intermediate probability category.

The highest proportion of normal scans was found in patients younger than age 30. However, when lung scans were abnormal, these young patients were much more likely than older patients to have high-probability findings.

Despite the high frequency of asymptomatic PE detected in their study, Meignan et al acknowledged that the cost-effectiveness of performing lung scans in all patients with DVT is unclear. The researchers also pointed out that submassive PE can be treated with the same dose of a low-molecular-weight heparin that is used for managing DVT. In their study, in which all patients were given treatment for DVT, the rate of recurrent PE (1.3% overall during three months' follow-up) was no higher in the patients with high-probability scans than in those with normal scans.

Thus, is it necessary to diagnose silent PE if outpatient treatment of DVT is being considered? "No," wrote Paul Stein, MD,[2] of the Henry Ford Heart and Vascular Institute in Detroit, Mich, in an accompanying editorial. He noted that in this study, the presence of PE did not appear to affect the frequency of recurrent thromboembolism or patient mortality.

However, he noted that even in many cases in which PE causes or contributes to death, it is unsuspected ante mortem. Thus, it remains unclear how extensively physicians should search for embolic disease--and exactly what they should do when asymptomatic PE is detected.

--Robert McCarthy

VTE Is Often Inappropriately Treated

HOUSTON--Pulmonary embolism is associated with significant morbidity and mortality; it has been recognized as either a cause or contributing factor in an estimated 200,000 deaths each year in the US. To address this problem, the American College of Chest Physicians published consensus guidelines for preventing venous thromboembolism (VTE; see Table 1).[1] Despite these recommendations, VTE prophylaxis remains widely underused, according to researchers led by Mark A. Stratton, PharmD of the University of Houston College of Pharmacy in Texas.[2]

As part of a retrospective study, the researchers reviewed the medical records of 1,907 patients who underwent one of four surgical procedures (major abdominal surgery, total hip replacement, hip fracture repair, or total knee replacement) and who had at least one risk factor for VTE. They found that while the percentage of patients who received "some" VTE preventative therapy was high (89.3% to 93.7% in the orthopedic patients; 75.2% in the abdominal surgery patients), those receiving the recommended therapies "varied from 45.2% in the hip fracture repair group to 84.3% in the total hip replacement group." Among the patients who underwent major abdominal surgery--74% of whom met criteria for very high risk--just over 50% received the recommended therapy.

Of the nearly 700 patients who did not receive the grade A recommended therapy for VTE, 204 (almost 30%) received no therapy at all; the remaining 490 received nonstandard therapy (mostly, elastic stockings). The researchers concluded that "publication of consensus statements alone may be insufficient to ensure incorporation of new clinical information into routine practice."

References

1. Clagett GP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest. 1995;108(suppl):312S-334S.

2. Stratton MA, Anderson FA, Bussey HI, Caprini J, et al. Prevention of venous thrombolembolism. Adherence to the 1995 American College of Chest Physicians Consensus Guidelines for Surgical Patients. Arch Intern Med. 2000;160:334-340.

 

References
1. Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med. 2000;160:159-164.
2. Stein PD. Silent pulmonary embolism. Arch Intern Med. 2000;160:145-146.

Return to table of contents